A detailed history of Doliver Advisors, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Doliver Advisors, LP holds 10,504 shares of NVO stock, worth $917,734. This represents 0.36% of its overall portfolio holdings.

Number of Shares
10,504
Previous 10,692 1.76%
Holding current value
$917,734
Previous $1.53 Million 18.09%
% of portfolio
0.36%
Previous 0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$119.07 - $145.42 $22,385 - $27,338
-188 Reduced 1.76%
10,504 $1.25 Million
Q2 2024

Jul 12, 2024

SELL
$122.71 - $146.91 $9,939 - $11,899
-81 Reduced 0.75%
10,692 $1.53 Million
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $1.1 Million - $1.46 Million
10,773 New
10,773 $1.38 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Doliver Advisors, LP Portfolio

Follow Doliver Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.